Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach

Acute myeloid leukemia (AML) is a disease, which mainly affects the elderly population. Unfortunately, the prognosis of patients aged >65 years is dismal, with 1-year overall survival approaching 10% with conventional therapies. The hypothesis of harnessing the immune system against cancer, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Isidori, Alessandro, Loscocco, Federica, Ciciarello, Marilena, Corradi, Giulia, Lecciso, Mariangela, Ocadlikova, Darina, Parisi, Sarah, Salvestrini, Valentina, Amadori, Sergio, Visani, Giuseppe, Curti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071222/
https://www.ncbi.nlm.nih.gov/pubmed/29932105
http://dx.doi.org/10.3390/cancers10070211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071222/
https://www.ncbi.nlm.nih.gov/pubmed/29932105
http://dx.doi.org/10.3390/cancers10070211

Ejemplares similares